AHMAD AWADA,
PROF, MD, PHD
Head of the Department of Oncology Medicine, Cancer Institute Jules Bordet, Brussels, ULB.
Active participation in the clinical development of new cancer drugs.
Member of several international scientific societies (ASCO, EORTC, ESMO).
Author or co-author of 32 book chapters and 330 articles in international publications.
SUSAN BATES,
PROF, MD, PHD
Studied at the University of Arkansas School of Medicine.
Clinical training in internal medicine at Georgetown University and in medical oncology at the National Cancer Institute.
Dr. Bates was chief clinical investigator and head of the Molecular Therapeutics Section in the Developmental Therapeutics Branch of the Center for Cancer Research before moving to Columbia University in 2015.
MARK DEWHIRST,
PROF, MD, PHD
Mark W. Dewhirst, DVM, PhD, FASTRO, FAAAS is the Emeritus Gustavo S. Montana Prof of Radiation Oncology, former Associate Dean for Faculty Mentoring and Vice Director for Basic Science at the Duke Cancer Institute.
Dr. Dewhirst has research interests in tumor hypoxia, angiogenesis, hyperthermia and drug transport and has had over 30 years of NIH funding to study these topics.
He has > 600 peer-reviewed publications, book chapters and reviews and received many awards.
ZELJKO VUJASKOVIC,
MD, PHD
Head of the Division of Translational Radiation Sciences in the Department of Radiation Oncology at the University of Maryland School of Medicine.
From 1999 to 2012, he was a clinical radiation oncologist and director of the Normal Tissue Injury Laboratory at Duke University. At Duke, he also directed the Clinical Hyperthermia Program.
Dr. Vujaskovic has published > 150 articles and book chapters on radiotherapy, radiation injury and hyperthermia topics.
Honored in 2016 with the J. Eugene Robinson Award from the Society for Thermal Medicine.
LIWEI WANG,
PROF, MD, PHD
Director of pancreatic cancer center of Shanghai Jiaotong University.
Chairman of MDT expert committee of Renji Hospital.
Chairman of Pancreatic Cancer Expert Committee of Chinese Soc. f Clin. Onco.
Chairman of the first “Chinese Expert Consensus on Pancreatic Cancer Diagnosis and Treatment.
Associate editor of Journal of Pancreatology, published more than 100 SCI publications.
STEPHAN BODIS,
PROF, MD, PHD
Professor of University Hospital Zurich & Cantonal Hospital Aarua, Switzerland.
He received his medical degree in 1984 from the Medical School of the University of Basel.
After several fellowships in Medical Oncology, Radiation Oncology, he was appointed Director of the Institute of Radiation Oncology at Kantonsspital Aarau in November 2003.
His work concerns clinical aspects of molecular radiobiology, the application of photon and proton radiotherapy and the combination of hyperthermia with radiotherapy in the treatment of various cancers.
JACOBA VAN DER ZEE,
MD, PHD
Studied medicine in Amsterdam and Leiden and obtained a PhD (subject Whole Body Hyperthermia) from Erasmus University.
Since 1978 involved in clinical research on hyperthermia as an adjunct to radiotherapy or chemotherapy at the Erasmus MC Cancer Institute.
(Co)author of >130 peer reviewed publications on different forms of hyperthermia.
Was president of the European Society for Hyperthermic Oncology from 1996 to 1999.
HANS CREZEE,
MSC, PHD
He obtained his MSc in Experimental Physics in 1986 (Free University of Amsterdam) and his PhD in 1993 (University of Utrecht).
His PhD research involved theoretical and experimental verification of thermal models used in the planning of hyperthermia treatments.
Since 2000 he has been working on clinical hyperthermia at the Department of Radiation Oncology of the Academic Medical Center in Amsterdam.
Since 2008 he has been Principal Investigator for hyperthermia system design and treatment planning.Awards : Dr. B.B. Singh Award 2010, ESHO-Pyrexar Award 2018.
JAAK J. JANSSENS,
PROF, MD, PHD
Oncologist; CEO Bioncise, Belgium.
Doctor honoris causa in personalized oncology and molecular biology.
As president of European Cancer Prevention and editor of the European Journal of Cancer Prevention, he leads an international team of cancer experts in various studies, especially breast cancer.
His work has been published in more than 200 scientific articles and books.
ALEX VAN DEN BOSSCHE,
DR. IR.
Research work in medical implantable devices for his doctoral thesis on the “Automatic Implantable Defribillator”.
Was co-founder of Krypton NV, a KULeuven high-tech spin-off company specialized in industrial optical metrology. He was managing director for 15 years until the successful sale of the company to Metris/Nikon.
He was co-founder of Allegro Investment Fund, specialized in technology.
Since 5 years he acquired GrindoSonic, a spin-off of KULeuven, specialized in measurement systems for material characterization and quality control.